The Role of the Prader-Willi Syndrome Critical Interval for Epigenetic Regulation, Transcription and Phenotype (2018)
Attributed to:
De-risking PWS drug development through preclinical screening
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/epigenomes2040018
Publication URI: http://dx.doi.org/10.3390/epigenomes2040018
Type: Journal Article/Review
Parent Publication: Epigenomes
Issue: 4